Surterra Wellness
55 Ivan Allen Blvd Ste 900, Atlanta, GA, 30308, United States
Overview
Surterra Wellness offers a wide variety of medical, health and wellness products in multiple delivery options, including vaporizer pens, tinctures, oral sprays, topical creams, time-released transdermal patches, and soft gels. Its brand portfolio includes Surterra Wellness, Florida's Finest, The Apothecary Shoppe, and Coral Reefer. The company operates vertically in Florida, Texas, Nevada and Massachusetts. Founded in 2014 by CEO William "Beau" Wrigley, Jr., Surterra has raised over $300M in private capital to date. The company intends to use new capital to fund strategic acquisitions and infrastructure capital expenditures. Surterra is based in Atlanta, GA. Surterra Wellness, based in Atlanta, is a medical cannabis company that offers a wide variety of products across multiple delivery options including vaporizer pens, tinctures, oral sprays, topical creams, time‑released transdermal patches and soon‑to‑be‑launched softgels. Led by CEO Jake Bergmann, the company operates 10 Wellness Centers across Florida and holds one of 14 vertically integrated medical marijuana licenses in Florida and one of three in Texas. Surterra supports state‑wide, next‑day delivery in Florida via three distribution centers and reports over 300,000 square feet of cultivation space. The company says its current footprint covers 49 million Americans in two of the nation’s fastest‑growing state populations. Surterra plans to use its recent funding to construct substantial cultivation space in Florida, execute partnerships with premier consumer brands, accelerate product development, and expand into new state markets. It also intends to conduct clinical research trials on cannabinoid treatments for anxiety, pain, PTSD and other significant health issues.
- Total raised
- $165M
- Funding rounds
- 2
- Latest round
- Series D
- Latest activity
- Jun 2019
Industries
- Cannabis
- E-Commerce
- Health Care
- Medical
- Wellness
Recent funding
Series D
Jun 2019
$100M
Series C
Aug 2018
$65M